Novavax set for India launch with Serum Institute as manufacturing partner

The large Novavax trials conducted on 29,960 persons in the US and Mexico have delivered results that equal the Pfizer and Moderna jabs and do better than J&J, but regulatory clearance appears distant as an overflowing vault of vaccines has diminished the need for emergency use approvals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3xla3Ur
via IFTTT